logo
Oman committed to social protection inclusion: ISSA

Oman committed to social protection inclusion: ISSA

Observer19-04-2025

Muscat: In a rapidly changing world shaped by demographic shifts, social protection has emerged as a vital safety net for societies facing modern-day risks. While progress is evident in expanding coverage, nearly 3.8 billion people remain completely unprotected, according to the ILO's World Social Protection Report 2024–2026.
In an interview with the Observer, Dr Mohammad Azman, President of the International Social Security Association (ISSA), said the world is witnessing a dual reality in the field of social protection. 'Systems have evolved in response to global crises, but the pace of expansion remains too slow. At this rate, achieving universal coverage could take decades. This is an issue of global equity. Every unprotected individual weakens the global safety net and leaves us more vulnerable to future shocks,' he said.
'Youth unemployment is especially alarming — about 13 per cent of young people globally are unemployed, and we'll need to create 600 million new jobs by 2030 to match the growing workforce,' he added, noting that chronic health conditions now account for 74 per cent of all global deaths, placing increasing strain on health and social systems.
At the same time, rising public expectations require social protection institutions to deliver better services — faster, more transparently, and with higher quality. 'The future demands systems that are resilient, inclusive, and innovative,' Dr Azman said, acknowledging that the existence of a gap between social protection systems in developing and developed countries. However, he stresses that this disparity is not purely economic.
'Coverage rates aren't solely dependent on development levels. They're shaped by policy choices and institutional capacities. Many developing countries ave made major strides — especially in health coverage — while some developed nations still struggle with gaps in coverage and benefit adequacy. What's needed is sustained investment, smart policymaking, and the sharing of best practices globally. Stronger protection anywhere benefits everyone," he said.
Dr Azman said, 'What distinguishes Oman is its bold commitment to inclusion. They've extended coverage to groups often left out — self-employed workers, entrepreneurs, those in informal sectors. It's a forward-looking response to today's labour market realities.' He also praises Oman's integration of multiple pension schemes under a single Social Protection Fund (SPF), calling it a strategic move toward improved governance and sustainability. 'The use of digital systems and integrated data management has made services more accessible and transparent. Oman is building a system that's responsive, people-centered, and ready for the future." On the relationship between ISSA and Oman, Dr Azman said Oman actively participates in ISSA's technical commissions, regularly shares good practices, and has aligned its reforms with international standards. 'This collaboration has been instrumental in supporting Oman's bold reforms,' he notes. 'The 2023 ISSA Good Practice Award for Asia and the Pacific — awarded to Oman — was a well-deserved recognition of this achievement." When asked how Oman can benefit from global experiences without repeating others' mistakes, Dr said, "Learning from others doesn't mean copying them.' He encourages Oman to study what has worked well — such as coverage expansion, governance improvements, and financial sustainability — while avoiding complex, costly systems that may not fit the local context.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tottenham reveal why they sacked Ange Postecoglou in lengthy club statement
Tottenham reveal why they sacked Ange Postecoglou in lengthy club statement

Daily Mail​

time15 minutes ago

  • Daily Mail​

Tottenham reveal why they sacked Ange Postecoglou in lengthy club statement

Tottenham Hotspur have issued a 368-word club statement in an attempt to justify the sacking of manager Ange Postecoglou. Spurs confirmed on Friday afternoon that Postecoglou would not be returning for a third campaign in charge following his post-season holiday. His dismissal was announced just 16 days after he oversaw a famous victory over Manchester United in the UEFA Europa League final. That win sealed a place in next season's Champions League. However, as mentioned in Friday's statement, Postecoglou also oversaw the club's worst ever Premier League season, which resulted in a 17th-place finish following 22 defeats. 'Following a review of performances and after significant reflection, the Club can announce that Ange Postecoglou has been relieved of his duties,' the statement began. 'Ange joined us from Celtic in the summer of 2023 and oversaw a period of change on the pitch, returning us to the attacking brand of football that has traditionally been associated with the Club, while writing a new chapter in our history by leading us to UEFA Europa League glory in Bilbao last month - an achievement that will live with us all forever. 'We are extremely grateful to Ange for his commitment and contribution during his two years at the Club. Ange will always be remembered as only the third manager in our history to deliver a European trophy, alongside legendary figures Bill Nicholson and Keith Burkinshaw. 'However, the Board has unanimously concluded that it is in the best interests of the Club for a change to take place. Following a positive start in the 2023/24 Premier League (PL) season, we recorded 78 points from the last 66 PL games. This culminated in our worst-ever PL finish last season. At times there were extenuating circumstances - injuries and then a decision to prioritise our European campaign. Whilst winning the Europa League this season ranks as one of the Club's greatest moments, we cannot base our decision on emotions aligned to this triumph. 'It is crucial that we are able to compete on multiple fronts and believe a change of approach will give us the strongest chance for the coming season and beyond. This has been one of the toughest decisions we have had to make and is not a decision that we have taken lightly, nor one we have rushed to conclude. We have made what we believe is the right decision to give us the best chance of success going forward, not the easy decision. 'We have a talented, young squad and Ange has given us a great platform to build upon. We should like to express our gratitude to him. We wish him well for the future - he will always be welcome back at our home. 'News on the appointment of a new Head Coach will be announced in due course.' Tottenham's statement explaining the sacking of Postecoglou was significantly longer than that granted to his predecessors. Spurs used just 111 words to in their official statement when Antonio Conte left the club, having published a 122-word message to signal the end of the Jose Mourinho era.

JCR Pharmaceuticals Marks 50 Years of Innovation with Launch of One-of-a-Kind Global Website
JCR Pharmaceuticals Marks 50 Years of Innovation with Launch of One-of-a-Kind Global Website

Business Wire

time16 minutes ago

  • Business Wire

JCR Pharmaceuticals Marks 50 Years of Innovation with Launch of One-of-a-Kind Global Website

HYOGO, Japan--(BUSINESS WIRE)-- JCR Pharmaceuticals Co., Ltd. (TSE 4552; 'JCR'), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the launch of its new global website. As the company turns 50, it is marking its growing footprint in Japan, the U.S., Europe, and Latin America with a unique website tailored for global audiences that reflects its passion for both science and humanity and brings the JCR brand to life for patients, physicians, and partners worldwide. 'At JCR, we are committed to advancing science and delivering on the treatments for patients with unmet needs around the world,' said Shin Ashida, Chairman, President and CEO of JCR Pharmaceuticals. 'In September, we celebrate the 50 th anniversary of the company I founded in 1975. The launch of our new global website reflects our evolution from an innovative startup in Japan to a global biopharmaceutical company. We remain dedicated to developing therapies for people with rare and genetic diseases and partnering with those who share our vision of transforming care for patients and families living with once untreatable diseases.' The site features streamlined user interface and curated content for patients, physicians, partners, and investors – reinforcing JCR's commitment to bridge the gap between complex science and unmet needs of patients and families. For the past 50 years, JCR has built a reputation for the development of innovative new therapeutic approaches, including its more recent J-Brain Cargo ® technology, a proprietary blood-brain barrier-penetrating technology that can deliver biotherapeutics into the central nervous system (CNS). This platform underpins several investigational pre-clinical and clinical staged therapies in JCR's pipeline, beginning with lysosomal storage disorders (LSDs), and it reflects the company's ongoing commitment to advancing treatments for CNS-related diseases across neurodegeneration, neuro-inflammation, and neuro-oncology conditions. JCR continues to strengthen its global research, development, and manufacturing capabilities, with a focus on addressing unmet medical needs and expanding therapeutic possibilities. Learn more about JCR, its technologies, and clinical development programs on its global website: About the J-Brain Cargo ® Platform Technology JCR Pharmaceuticals has developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo ®, to bring biotherapeutics into the central nervous system. The first drug developed based on this technology and approved in Japan for the treatment a lysosomal storage disorder is IZCARGO ® (INN: pabinafusp alfa). About JCR Pharmaceuticals Co., Ltd. JCR Pharmaceuticals Co., Ltd. (TSE 4552) is a global specialty pharmaceutical company that develops treatments that go beyond rare diseases to solve the world's most complex healthcare challenges. We continue to build upon our 50-year legacy in Japan while expanding our global footprint into the U.S., Europe, and Latin America. We improve patients' lives by applying our scientific expertise and unique technologies to research, develop, and deliver next-generation therapies. Our approved products in Japan include therapies for the treatment of growth disorder, MPS II (Hunter syndrome), Fabry disease, acute graft-versus host disease, and renal anemia. Our investigational products in development worldwide are aimed at treating rare diseases including MPS I (Hurler, Hurler-Scheie and Scheie syndrome), MPS II, MPS IIIA and B (Sanfilippo syndrome type A and B), and more. Our core values – Putting people first, Forging our own path, Always advancing, and Committed to excellence – mean that the work we do benefits all our stakeholders, including employees, partners, and patients. We strive to expand the possibilities for patients while accelerating medical advancement at a global level. For more information, please visit the global website:

Murder arrest after woman found dead in flat in Derby
Murder arrest after woman found dead in flat in Derby

BBC News

time16 minutes ago

  • BBC News

Murder arrest after woman found dead in flat in Derby

A man has been arrested on suspicion of murder after a 47-year-old woman was found dead in a were called to the property in Ashe Place, in Normanton, Derby, at about 11:30 BST on investigation has been launched into the cause of her death, police force said this was believed to be an isolated incident, adding a 63-year-old suspect remained in police custody. Ch Insp Lauren Woods said: "As there has been an increased police presence in the area recently we are aware that this may be causing the community concern. "We would like to provide reassurance that this incident is believed to be isolated and took place inside a property."Please feel free to approach them with any information you may have that could help our investigation."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store